Cleared Traditional

K921270 - SAFE-DWELL PLUS CENTRAL VENOUS CATHETER

K921270 is an FDA 510(k) clearance for SAFE-DWELL PLUS CENTRAL VENOUS CATHETER, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 195-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
195d
Days
Class 2
Risk

K921270 is an FDA 510(k) clearance for the SAFE-DWELL PLUS CENTRAL VENOUS CATHETER. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Sandy, US). The FDA issued a Cleared decision on September 28, 1992 after a review of 195 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K921270

510(k) Number K921270 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received March 17, 1992
Decision Date September 28, 1992
Days to Decision 195 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 129d · This submission: 195d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 507
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K921270.
HOLE PUNCH
K915824 · American Biomaterials Corp. · Jan 1993
QUIK FLOW
K921955 · California Medical Equipment, Inc. · Jan 1993
SAFEDWEL(R) CENTRAL VENOUS CATHETER
K914528 · Becton Dickinson Vascular Access, Inc. · Oct 1992
SAFE-PICC PERIPHERALLY INSERTED CENTRAL VENOUS CAT
K920828 · Menlo Care, Inc. · Aug 1992
DESERET(R) FLOW RESTRICTION VALVE
K914180 · Becton Dickinson Vascular Access, Inc. · May 1992
E-Z SET/MINICATH INFUSION SETS
K920635 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1992